Bristol-Myers Squibb (BMY) Stock Highlights

57.33 | +1.83%

2024-12-21 00:09:14

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.

Statistics

Range Today

56.08 57.33

Volume Today 14.92M

Range 1 Year

39.35 61.08

Volume 1 Year 3.54B

Range 3 Year

39.35 81.44

Volume 3 Year 9.12B

Range 10 Year

39.35 81.44

Volume 10 Year 27.27B

Highlights

Market Capitalization 116.28B (large)

Floating Shares 2.02B

Current Price 57.33

Price To Earnings -15.7

Price To Revenue 3.32

Price To Book 6.78

Earnings Per Share -3.58

Dividend Yield 4.4%

Dividend Per Share 2.48

Payout Ratio 59.84%

Performance

Latest +1.83%

1 Month -2.18%

3 Months +16.31%

6 Months +41.38%

1 Year +10.19%

3 Years -6.69%

5 Years -9.83%

10 Years -5.89%

Benchmarks

Market Capitalization

9 / 14

Gross Profits

6 / 14

Total Revenue

7 / 14

Total Rank

4 / 14

Free Cashflow

5 / 14

Performance 5 years

9 / 14

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.